Table 4. Results of sensitivity analysis of meta-analysis for ADPIOQ rs1501299 polymorphisms and CAD in type 2 diabetic patients.

	T VS G		TT+TG VS GG		TT VS TG+GG		GT VS GG		TT VS GG
Study group 2	OR[95%CI]	I2(%)/Ph	OR[95%CI]	I2/Ph	OR[95%CI]	I2/Ph	OR[95%CI]	I2/Ph	OR[95%CI]	I2/Ph
Total	0.91[0.78,1.07]	64/0.003	0.95[0.78,1.16]	63/0.004	0.40[0.22,0.71]	84/0.000	1.00[0.82,1.21]	56/0.020	0.67[0.54,0.83]	36/0.120
Mohammadzadeh2016	0.86[0.76,0.98]	46/0.06	0.89[0.75,1.05]	49/0.05	0.34[0.19,0.60]	84/0.000	0.95[0.79,1.13]	45/0.070	&	&
Katakami2012	0.94[0.79,1.12]	64/0.04	0.99[0.80,1.23]	61/0.009	0.39[0.21,0.73]	86/0.000	1.05[0.86,1.27]	50/0.040	&	&
Esteghamati2012	0.94[0.81,1.10]	59/0.01	0.99[0.82,1.20]	58/0.02	0.47[0.33,0.67]	49/0.050	1.04[0.86,1.25]	50/0.040	&	&
Al-Daghri2011	0.90[0.76,1.07]	67/0.002	0.95[0.76,1.18]	67/0.002	0.39[0.20,0.74]	86/0.000	1.00[0.81,1.24]	61/0.009	&	&
Chiodini2010	0.94[0.79,1.12]	63/0.006	0.98[0.78,1.23]	64/0.005	0.37[0.20,0.71]	83/0.000	1.03[0.82,1.28]	58/0.010	&	&
Qi2006	0.92[0.76,1.10]	68/0.002	0.96[0.76,1.21]	67/0.002	0.41[0.21,0.79]	86/0.000	1.01[0.81,1.26]	61/0.009	&	&
Qi2005	0.90[0.76,1.08]	66/0.003	0.93[0.74,1.15]	63/0.005	0.42[0.22,0.81]	86/0.000	0.97[0.79,1.19]	54/0.020	&	&
Lacquemant Swiss2004	0.91[0.77,1.08]	68/0.002	0.95[0.76,1.17]	67/0.002	0.38[0.21,0.72]	86/0.000	1.00[0.81,1.23]	61/0.009	&	&
Lacquemant French2004	0.89[0.76,1.04]	63/0.006	0.94[0.76,1.17]	66/0.002	0.38[0.21,0.71]	86/0.000	0.97[0.80,1.18]	57/0.020	&	&
Bacci2004	0.92[0.77,1.09]	68/0.002	0.92[0.75,1.12]	63/0.006	0.42[0.22,0.78]	86/0.000	0.97[0.79,1.20]	58/0.010	&	&

Abbreviations: Ph, P value for heterogeneity from Q-test; I2, the proportion of the total variation across studies due to heterogeneity; CI, confidence interval; OR, odds ratio.

&No heterogeneity was observed in the homozygote model.

Significant results are marked in bold.